| 3. Good health and well-being |
- A wide variety of hormonal products in the field of obstetrics and gynecology
- Pharmaceuticals for the treatment of hepatic encephalopathy, a rare disease
- Thyroid hormone preparations that have been used for about 100 years
- Highly accurate LC-MS/MS sample measurement using proprietary technology
- Health management
|
|
P9-P10 P17-P18 P24-P44
|
P12-P13 P19-P23 |
P25-P26 |
| 5. Gender equality |
- Oral and emergency contraceptives
- Uterine fibroids and endometriosis agent
- Dysmenorrhea agent
- Fertility Agents
- Eclampsia control and agent
- Highly accurate steroid hormone measurement for preventive medicine and improvement of
unwellness
- Location-specific medical representative system
- Telecommuting system
- Granting of annual leave in increments of hours
- Introduced pioneering hourly "child nursing care leave and nursing care leave" program
- Paid childcare leave
- Target for male employees taking childcare leave: 100%
|
|
P5-P10 P17-P30
|
P16-P19 |
P16-P19 |
| 7. Affordable and clean energy |
- Promote energy conservation activities
- Reduction of greenhouse gas emissions (conversion from heavy oil to city gas)
- Establishment and operation of environmental management systems, etc.
- Reduce unit energy consumption of all group companies by 1% or more compared to the
previous year
|
|
P49-P52
|
P14-P16 |
P2-P14 |
| 12. Responsible consumption and production |
- Ensure appropriate inventory by utilizing our own factories, contract manufacturers, and
external warehouses
- Operation of quality systems in pharmaceuticals (management review with management
participation)
- Steady implementation of risk management plans for ethical pharmaceuticals, etc.
|
|
P5-P10 P17-P32 P37-P48
|
P14-P16 |
P1-P33
|
| 13. Climate action |
- Promote energy conservation activities
- Reduction of greenhouse gas emissions (conversion from heavy oil to city gas)
- Establishment and operation of environmental management systems, etc.
- Reduce unit energy consumption of all group companies by 1% or more compared to the
previous year
|
|
P17-P18 P27-P28 P49-P52
|
P13-P16 |
P2-P14 |
| 14. Life below water |
- A wide variety of reproductive hormones
- Oxytocin Injection Solution for Veterinary Use
- Mixed feed (Best Balance Series), etc.
|
|
P17-P18 P27-P28 P49-P52
|
P13-P16 |
P2-P14 |
| 15. Life on land |
- A wide variety of reproductive hormones
- Oxytocin Injection Solution for Veterinary Use
- Mixed feed (Best Balance Series), etc.
|
|
P17-P18 P27-P28 P49-P52
|
P13-P16 |
P2-P14 |
| 16. Peace justice and strong institutions |
- Ensure substantial equality of shareholders
- Fostering a corporate culture and climate that respects sound business ethics
- Ensuring Transparency
- Effective supervision of directors
- Constructive dialogue with shareholders
|
|
P17-P18 P27-P30 P69-P76
|
P13-P16 |
P27-P33 |
| 17. Partnerships for the goals |
- Enhancement of Testing Technology and Drug Discovery Functions in Shonan iPark through
Collaboration with Other Companies
- Addition of pediatric dosage and indication for existing pharmaceuticals, etc.
- Veterinary pharmaceuticals developed from ethical pharmaceuticals
|
|
P17-P18 P27-P30 P36-P48
|
P5-P13 P23-P26 |
P33
|